These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26096534)

  • 1. "Hepatitis C treatment turned me around:" Psychological and behavioral transformation related to hepatitis C treatment.
    Batchelder AW; Peyser D; Nahvi S; Arnsten JH; Litwin AH
    Drug Alcohol Depend; 2015 Aug; 153():66-71. PubMed ID: 26096534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.
    Li ZB; Zhang L; Wang J; Huang LP; Zhou ZR; Cao YN; Zhao M; Du J
    Harm Reduct J; 2017 Nov; 14(1):71. PubMed ID: 29096647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.
    Safo SA; Batchelder A; Peyser D; Litwin AH
    Harm Reduct J; 2015 Jun; 12():20. PubMed ID: 26092261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance.
    Zeremski M; Dimova RB; Zavala R; Kritz S; Lin M; Smith BD; Zibbell JE; Talal AH
    J Addict Med; 2014; 8(4):249-57. PubMed ID: 24820257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.
    Rance J; Newland J; Hopwood M; Treloar C
    Soc Sci Med; 2012 Jan; 74(2):245-53. PubMed ID: 22133583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "It gives me a sense of belonging": providing integrated health care and treatment to people with HCV engaged in a psycho-educational support group.
    Woolhouse S; Cooper E; Pickard A
    Int J Drug Policy; 2013 Nov; 24(6):550-7. PubMed ID: 23860471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan.
    Ng MH; Chou JY; Chang TJ; Lee PC; Shao WC; Lin TY; Chen VC; Gossop M
    Addict Behav; 2013 Apr; 38(4):2089-93. PubMed ID: 23403277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Take Charge, Get Cured": Pilot testing a targeted mHealth treatment decision support tool for methadone patients with hepatitis C virus for acceptability and promise of efficacy.
    Jessop AB; Bass SB; Brajuha J; Alhajji M; Burke M; Gashat MT; Wellington C; Ventriglia N; Coleman J; D'Avanzo P
    J Subst Abuse Treat; 2020 Feb; 109():23-33. PubMed ID: 31856947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.
    Treloar C; Newland J; Rance J; Hopwood M
    J Viral Hepat; 2010 Dec; 17(12):839-44. PubMed ID: 20070504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of methadone maintenance treatment patients prescribed opioid analgesics.
    Glenn MC; Sohler NL; Starrels JL; Maradiaga J; Jost JJ; Arnsten JH; Cunningham CO
    Subst Abus; 2016; 37(3):387-391. PubMed ID: 26731299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
    Ayres R; Ingram J; Rees A; Neale J; Beattie A; Telfer M
    Subst Abuse Treat Prev Policy; 2014 Nov; 9():44. PubMed ID: 25407020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
    Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
    Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions of Barriers and Benefits of HCV Treatment and Correlates to Treatment Intention in Methadone Patients.
    Jessop AB; Bass SB; Gutierrez M; Gashat MT
    J Health Care Poor Underserved; 2019; 30(4):1433-1454. PubMed ID: 31680107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
    Litwin AH; Soloway I; Gourevitch MN
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S339-45. PubMed ID: 15768345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection is independently associated with depression among methadone maintenance treatment heroin users in China.
    Wang Z; Du J; Zhao M; Page K; Xiao Z; Mandel JS
    Asia Pac Psychiatry; 2013 Sep; 5(3):191-6. PubMed ID: 23857926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with viral hepatitis C treatment among people who inject drugs and participate in a methadone substitution treatment program.
    Krekulová L; Vavrinčíková L
    Epidemiol Mikrobiol Imunol; 2021; 70(1):18-25. PubMed ID: 33853334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Not just methadone Tracy': transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings.
    Rance J; Treloar C;
    Addiction; 2014 Mar; 109(3):452-9. PubMed ID: 24678545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge about Hepatitis-C among methadone maintenance treatment patients in Israel.
    Cohen-Moreno R; Schiff M; Levitt S; Bar-Hamburger R; Strauss S; Neumark Y
    Subst Use Misuse; 2010; 45(1-2):58-76. PubMed ID: 20025439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
    Brown JL; Gause NK; Lewis D; Winhusen T
    J Subst Abuse Treat; 2017 May; 76():77-80. PubMed ID: 28162850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.
    Swan D; Long J; Carr O; Flanagan J; Irish H; Keating S; Keaveney M; Lambert J; McCormick PA; McKiernan S; Moloney J; Perry N; Cullen W
    AIDS Patient Care STDS; 2010 Dec; 24(12):753-62. PubMed ID: 21138381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.